openPR Logo
Press release

Lung Cancer Screening Software Market 2022: Analysis By Demands, Future Trends, Growth Factors, Business Strategy, Leading Players, Price and Gross Margin till 2029

12-08-2022 03:27 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Lung Cancer Screening Software Market

Lung Cancer Screening Software Market

The large scale Lung Cancer Screening Software market report puts on view systemic company profiles which illustrate how the moves of several key players and brands are driving the market. The report provides with a top to bottom examination of the market as far as income and developing business sector is concerned. It also covers predictions regarding reasonable arrangement of uncertainties and latest techniques. This market report covers wide scope that takes into account market scenarios, comparative pricing between major players, expenditure and profit of the specified market regions. The significant Lung Cancer Screening Software market report also carries out study on the market drivers and market restraints which are derived from SWOT analysis.This market report also puts light on historic data, present market trends, future products environment, marketing strategies, technological innovation, upcoming technologies, emerging opportunities, and the technical progress in the related industry. CAGR levels for the market with respect to its rise or fall are estimated in the report for the forecast period of 2022 to 2029.

Data Bridge Market Research analyzes that the global lung cancer screening software market is expected to reach the value of USD 115,027.61 thousand by 2029, at a CAGR of 19.4% during the forecast period.

Get Sample Copy of this Report at: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lung-cancer-screening-software-market

Top Companies Listed Here:

PenRad Technologies Inc., Koninklijke Philips N.V, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmbH, MyCareWare, Inc., MagView, MeVis Medical Solutions AG, Canon Medical Informatics, Inc., General Electric Company, Epic Systems Corporation, Lungview, Eon, Medtronic, Coreline Soft Co., Ltd., Optellum Ltd, HealthMyne, Oncocyte Corporation, Genesystem, REVEALDX, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd, Median Technologies, AstraZeneca and Aidence.com

Market Segmentation Overview:

By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions and Web Based Solutions)

By Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking)

By Type (Computer-Assisted Screening and Traditional Screening), Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), Platform (Standalone and Integrated)

By Purchase Mode (Institutional and Individual)

By End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers and Others)

By Distribution Channel (Direct Tender and Third Party Distributors)

View Full Report: https://www.databridgemarketresearch.com/reports/global-lung-cancer-screening-software-market

Geographical scope:

The countries covered in this market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, U.A.E., Saudi Arabia, Israel, Egypt, South Africa, and rest of Middle East and Africa.

North America region is expected to dominate the market and is the fastest-growing region owing to the factors such as increasing number of screening programs, growing adoption of software solutions for patient management, rise in the demand for screening with chest radiography and the presence of large number of screening centers.

Lung Cancer Screening Software Market Overiew

Lung cancer screening is identifying stages of lung cancer using different technologies and software. Lung cancer screening using CT is the most recommended technique for screening lung cancer. The rising use of this technique is expected to accelerate the need for advanced software for lung cancer screening. This software helps to manage patients' participation in lung screening programs and provides an efficient way for healthcare professionals to collect, curate and transfer data to clinicians and patients. In addition, this software enables in the identification of patients at risk and automates the flow of data with integrated electronic health records.

Control of lung cancer death rates is one of the major concerns for healthcare facilities. Public and private organizations are taking initiatives to launch screening programs to control the death rates. In addition, companies are launching advanced software to ease the management of patients' data and provide better care with strict data privacy guidelines.

Increase in prevalence of lung cancer, rising awareness among people about lung cancer, increasing government initiatives and growing number of screening programs are some of the major factors driving the growth of the market. In addition, advancement in Artificial Intelligence (AI)-based solutions and strategic initiatives by key market players are creating opportunities in the field of lung cancer screening software.

View the Entire report with Table of Contents: https://www.databridgemarketresearch.com/toc/?dbmr=global-lung-cancer-screening-software-market

Global Lung Cancer Screening Software Market Dynamics

Drivers

Increase in prevalence of lung cancer cases globally

Lung cancer is a leading cause of death in men and women. According to World Cancer Research Fund International, lung cancer is the second most common cancer worldwide. It is the most common cancer in men and second most common in women. There were more than 2.2 thousand new cases of lung cancer in 2020. Increasing prevalence of lung cancer cases creates need to adopt lung cancer screening software for early diagnosis and thus, acts as a driving factor for the market growth.

Increase in awareness regarding the benefits of early diagnosis and frequent screening

The rising awareness programs of lung cancer by public, non-profit and private organizations are anticipated to boost the market growth. These initiatives aim to prevent diseases, reduce stigma and prejudice and promote research. The awareness among the population regarding lung cancer has increased. Because there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed early. Thus, raising awareness among populations is driving the market growth.

Government initiatives were undertaken to implement screening programs for various diseases

The burden of cancer continues to increase globally and has great financial, emotional and physical stress on health systems, products, families and individuals. In countries with strong health systems, the survival rate of many types of cancer is improved due to survivorship, quality care, increased awareness and accessible early detection. Centers for Disease Control and Prevention, U.S., tribes and the U.S.-Pacific islands and territories through the National Comprehensive Cancer Control Program (NCCCP) are to form or support alliances to combat cancer in their communities. Due to these initiatives, more audiences are educated and more consciously dispersed, pushing the global audience to take further precautions and practice preventive examinations, promoting the market.

Growing number of screening programs across the globe

Screening is an effective method of detecting early-stage cancer. There is an increasing trend in lung cancer incidences in developing countries. Although there are regular recommendations for screening for breast and cervical cancer, it is not the same in case of lung cancer. Most countries or institutions have initiated the feasibility and disease screening of Low-Dose Computed Tomography (LDCT) for lung cancer. The increasing number of lung cancer screening has created an opportunity for the market players. Hence, the increasing diagnostic rate acts as a driving factor for market growth.

Many product launches and agreements are also initiated by the companies worldwide, which are further accelerating the global Lung Cancer Screening Software market.

In July 2022, GE Healthcare launched their latest product and most advanced ultrasound, the next-generation Voluson Expert 22. This latest addition to GE Healthcare's award-winning Women's Health portfolio utilizes graphic-based beam former technology, which produces higher quality images and offers greater flexibility in imaging functions. With this product, the company made its position much stronger in the area of products and service providers to healthcare institutions.

In October 2021, Thynk Health announced a partnership with Infervision, to fight lung cancer with the world's most advanced technologies. It offers an opportunity for lung cancer screening and pulmonary nodule management. With this partnership, the company increased its market presence.

The market research report titled Lung Cancer Screening Software contains company analysis, history, and future overview, global sales trends by 2029. The report will be one of the most comprehensive and important additions for growth of the business through market research studies. This business report comprises of all the market shares and approaches of key players in the market. It also comprises of the detailed profiles for the market's major manufacturers and importers who are influencing the market. Competitive landscape analysis is conducted based on the prime manufacturers, trends, opportunities, marketing strategies analysis, market effect factor analysis and consumer needs by major regions, types, applications in global Lung Cancer Screening Software market considering the past, present and future state of the industry.

Any Query About Lung Cancer Screening Software Market? Enquire Here With Our Experts @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-lung-cancer-screening-software-market

Explore DBMR Comprehensive Coverage on Healthcare Domain:

Global open-angle glaucoma Market: https://www.databridgemarketresearch.com/reports/global-open-angle-glaucoma-market

Global Transdermal Drugs Market: https://www.databridgemarketresearch.com/reports/global-transdermal-drugs-market

Global Uveitis Market: https://www.databridgemarketresearch.com/reports/global-uveitis-market

Global Antispasmodics Drugs Market: https://www.databridgemarketresearch.com/reports/global-antispasmodics-drugs-market

China Injectable Drug Delivery Devices Market: https://www.databridgemarketresearch.com/reports/china-injectable-drug-delivery-devices-market

Global Pompe Disease Market: https://www.databridgemarketresearch.com/reports/global-pompe-disease-market

Global Cataracts Market: https://www.databridgemarketresearch.com/reports/global-cataracts-market

Global Cubital Tunnel Syndrome Market: https://www.databridgemarketresearch.com/reports/global-cubital-tunnel-syndrome-market

Contact Us:-
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email us:-sopan.gedam@databridgemarketresearch.com

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lung Cancer Screening Software Market 2022: Analysis By Demands, Future Trends, Growth Factors, Business Strategy, Leading Players, Price and Gross Margin till 2029 here

News-ID: 2841107 • Views:

More Releases from Data Bridge Market Research

Water Treatment System Market: Sustaining the Future of Clean Water
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction Understanding Water Treatment Systems Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use. Importance in Global Sustainability Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal

All 5 Releases


More Releases for Lung

Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: Core Growth Enabler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Lung Cancer Drugs Industry Market Size Be by 2025? The market for lung cancer medications has seen a swift expansion in previous years. The market size is projected to escalate from $47.94 billion in 2024 to $54.13 billion in 2025, with a compound annual growth rate
Lung Cancer Prevalence Driving The Lung Cancer Drugs Market: An Emerging Driver …
The Lending And Payments Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Lending And Payments Market? The lending and payments market has experienced strong growth in recent years. It is set to rise from $12,326.44 billion in 2024 to
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Transforming the Lung Cancer Drugs Market in 2025: Lung Cancer Prevalence Drivin …
What Is the Expected Size and Growth Rate of the Lung Cancer Drugs Market? The market size for lung cancer medications has seen swift expansion in the recent past. Its growth is projected to surge from $47.94 billion in 2024 to $54.13 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the historical period's growth include epidemiology and demographics, regulatory authorizations, healthcare system infrastructure, and
Lung Cancer Screening Market - Empowering Proactive Lung Health: The Future of C …
Newark, New Castle, USA: The "Lung Cancer Screening Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Lung Cancer Screening Market: https://www.growthplusreports.com/report/lung-cancer-screening-market/7787 This latest report researches the industry structure,
Artificial Lung Market May Set New Growth Story | Breethe, Lung Biotechnology, M …
A new research document is added in HTF MI database of 37 pages, titled as 'Artificial Lung - Medical Devices Pipeline Assessment, 2020' with detailed analysis, Competitive landscape, forecast and strategies. The study covers important players/vendors such as ALung Technologies Inc, Breethe, Inc., Case Western Reserve University, Lung Biotechnology PBC, MC3 Inc, McGowan Institute for Regenerative , Medicine, Miromatrix Medical Inc, The Charles Stark Draper Laboratory Inc, U.S. Ann Arbor